The store will not work correctly when cookies are disabled.
(2R,3R,5S)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolan-3-ol
ID: ALA3110070
Cas Number: 15386-69-3
PubChem CID: 9881867
Max Phase: Preclinical
Molecular Formula: C10H12FN5O3
Molecular Weight: 269.24
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)C[C@H]1O
Standard InChI: InChI=1S/C10H12FN5O3/c11-10-14-7(12)6-8(15-10)16(3-13-6)9-5(18)1-4(2-17)19-9/h3-5,9,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,9+/m0/s1
Standard InChI Key: PCVQISHHKVORII-OBXARNEKSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
12.9137 -6.7340 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5904 -7.1988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3580 -7.9905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5357 -8.0114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2573 -7.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8642 -8.6446 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4691 -7.0020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8987 -7.6000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.7062 -6.8876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0499 -7.3902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3710 -6.9217 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6033 -6.1301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1716 -5.4270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5658 -4.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3881 -4.6801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8198 -5.3831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4292 -6.1070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1341 -3.9979 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.6457 -5.3600 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
3 6 1 6
7 8 1 0
5 7 1 1
9 10 2 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
9 17 1 0
12 17 1 0
14 18 1 0
16 19 1 0
2 11 1 1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 269.24 | Molecular Weight (Monoisotopic): 269.0924 | AlogP: -0.81 | #Rotatable Bonds: 2 |
Polar Surface Area: 119.31 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.53 | CX Basic pKa: 0.76 | CX LogP: -0.78 | CX LogD: -0.78 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.61 | Np Likeness Score: 1.10 |
References
1. Vodnala SK, Lundbäck T, Yeheskieli E, Sjöberg B, Gustavsson AL, Svensson R, Olivera GC, Eze AA, de Koning HP, Hammarström LG, Rottenberg ME.. (2013) Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis., 56 (24): [PMID:24283924] [10.1021/jm401530a] |